Goldman Sachs’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-395,271
| Closed | -$3.55M | – | 4753 |
|
|
2016
Q3 | $3.55M | Sell |
395,271
-2,358,228
| -86% | -$21.2M | ﹤0.01% | 2424 |
|
|
2016
Q2 | $14.8M | Buy |
2,753,499
+98,734
| +4% | +$530K | ﹤0.01% | 1555 |
|
|
2016
Q1 | $12.2M | Buy |
2,654,765
+679
| +0% | +$3.12K | ﹤0.01% | 1623 |
|
|
2015
Q4 | $13.8M | Sell |
2,654,086
-8,178
| -0.3% | -$42.5K | ﹤0.01% | 1515 |
|
|
2015
Q3 | $16.1M | Sell |
2,662,264
-57,386
| -2% | -$347K | 0.01% | 1391 |
|
|
2015
Q2 | $42.9M | Buy |
2,719,650
+121,896
| +5% | +$1.92M | 0.01% | 938 |
|
|
2015
Q1 | $28.2M | Buy |
2,597,754
+180,368
| +7% | +$1.96M | 0.01% | 1163 |
|
|
2014
Q4 | $25.4M | Buy |
2,417,386
+544,866
| +29% | +$5.73M | 0.01% | 1191 |
|
|
2014
Q3 | $18M | Sell |
1,872,520
-2,002,662
| -52% | -$19.2M | 0.01% | 1305 |
|
|
2014
Q2 | $44.8M | Buy |
3,875,182
+1,074,427
| +38% | +$12.4M | 0.01% | 878 |
|
|
2014
Q1 | $28M | Sell |
2,800,755
-90,400
| -3% | -$904K | 0.01% | 1069 |
|
|
2013
Q4 | $37.6M | Buy |
2,891,155
+2,878,358
| +22,492% | +$37.5M | 0.01% | 912 |
|
|
2013
Q3 | $191K | Sell |
12,797
-14,765
| -54% | -$220K | ﹤0.01% | 3861 |
|
|
2013
Q2 | $258K | Buy |
+27,562
| New | +$258K | ﹤0.01% | 3513 |
|